Roberto Massa

Summary

Affiliation: University of Rome Tor Vergata
Country: Italy

Publications

  1. ncbi Late-onset MNGIE without peripheral neuropathy due to incomplete loss of thymidine phosphorylase activity
    Roberto Massa
    Department of Neurosciences, University of Rome Tor Vergata and IRCCS Fondazione S Lucia, Via Montpellier 1, I 00135 Rome, Italy
    Neuromuscul Disord 19:837-40. 2009
  2. ncbi Intracellular localization and isoform expression of the voltage-dependent anion channel (VDAC) in normal and dystrophic skeletal muscle
    R Massa
    Dipartimento di Neuroscienze, Laboratorio di Medicina Molecolare, Universita di Roma Tor Vergata, Italy
    J Muscle Res Cell Motil 21:433-42. 2000
  3. ncbi Sural nerve without nerve fibers in leprous neuropathy
    Roberto Massa
    Clinica Neurologica, Dipartimento di Neuroscienze, , Via di Tor Vergata 135, I-00133 Rome, Italy
    Arch Neurol 59:306. 2002
  4. ncbi Adult polyglucosan body disease: proton magnetic resonance spectroscopy of the brain and novel mutation in the GBE1 gene
    Roberto Massa
    Dipartimento di Neuroscienze, Università di Roma Tor Vergata and Fondazione Santa Lucia, Roma, Italy
    Muscle Nerve 37:530-6. 2008
  5. ncbi The myotonic dystrophy type 2 (DM2) gene product zinc finger protein 9 (ZNF9) is associated with sarcomeres and normally localized in DM2 patients' muscles
    R Massa
    Department of Neurosciences, Tor Vergata University of Rome, Via Montpellier 1, I 00133, Rome, Italy
    Neuropathol Appl Neurobiol 36:275-84. 2010
  6. ncbi Preferential central nucleation of type 2 myofibers is an invariable feature of myotonic dystrophy type 2
    Valerio Pisani
    Department of Neurosciences, Universita di Roma Tor Vergata, and IRCCS Fondazione Santa Lucia, Via Montpellier 1, I 00133, Rome, Italy
    Muscle Nerve 38:1405-11. 2008
  7. ncbi Overexpression of ErbB2 and ErbB3 receptors in Schwann cells of patients with Charcot-Marie-tooth disease type 1A
    Roberto Massa
    Dipartimento di Neuroscienze, Universita di Roma Tor Vergata, Via Montpellier 1, I 00133 Roma, Italy
    Muscle Nerve 33:342-9. 2006
  8. ncbi Effect of the [CCTG]n repeat expansion on ZNF9 expression in myotonic dystrophy type II (DM2)
    Annalisa Botta
    Department of Biopathology, Tor Vergata University, Rome, Italy
    Biochim Biophys Acta 1762:329-34. 2006
  9. ncbi Risk prediction for clinical phenotype in myotonic dystrophy type 1: data from 2,650 patients
    Leila Baghernajad Salehi
    Department of Biopathology and Diagnostic Imaging, Tor Vergata University, Rome, Italy
    Genet Test 11:84-90. 2007
  10. ncbi Inverse correlation between VEGF and soluble VEGF receptor 2 in POEMS with AIDP responsive to intravenous immunoglobulin
    Chiara Terracciano
    Department of Neurosciences, Tor Vergata University of Rome and IRCCS Fondazione Santa Lucia, Rome, Italy
    Muscle Nerve 42:445-8. 2010

Collaborators

Detail Information

Publications16

  1. ncbi Late-onset MNGIE without peripheral neuropathy due to incomplete loss of thymidine phosphorylase activity
    Roberto Massa
    Department of Neurosciences, University of Rome Tor Vergata and IRCCS Fondazione S Lucia, Via Montpellier 1, I 00135 Rome, Italy
    Neuromuscul Disord 19:837-40. 2009
    ..TYMP/ECGF1 analysis detected two heterozygous mutations, including a novel missense mutation. These findings indicate that a partial loss of thymidine phosphorylase activity may induce a late-onset and incomplete MNGIE phenotype...
  2. ncbi Intracellular localization and isoform expression of the voltage-dependent anion channel (VDAC) in normal and dystrophic skeletal muscle
    R Massa
    Dipartimento di Neuroscienze, Laboratorio di Medicina Molecolare, Universita di Roma Tor Vergata, Italy
    J Muscle Res Cell Motil 21:433-42. 2000
    ..This finding suggests a possible involvement of VDAC3 expression in the early pathogenic events of the mdx muscular dystrophy...
  3. ncbi Sural nerve without nerve fibers in leprous neuropathy
    Roberto Massa
    Clinica Neurologica, Dipartimento di Neuroscienze, , Via di Tor Vergata 135, I-00133 Rome, Italy
    Arch Neurol 59:306. 2002
  4. ncbi Adult polyglucosan body disease: proton magnetic resonance spectroscopy of the brain and novel mutation in the GBE1 gene
    Roberto Massa
    Dipartimento di Neuroscienze, Università di Roma Tor Vergata and Fondazione Santa Lucia, Roma, Italy
    Muscle Nerve 37:530-6. 2008
    ....
  5. ncbi The myotonic dystrophy type 2 (DM2) gene product zinc finger protein 9 (ZNF9) is associated with sarcomeres and normally localized in DM2 patients' muscles
    R Massa
    Department of Neurosciences, Tor Vergata University of Rome, Via Montpellier 1, I 00133, Rome, Italy
    Neuropathol Appl Neurobiol 36:275-84. 2010
    ..The aim of the present work was therefore to assess ZNF9 protein expression in rat tissues and in human muscle, and ZNF9 subcellular distribution in normal and DM2 human muscles...
  6. ncbi Preferential central nucleation of type 2 myofibers is an invariable feature of myotonic dystrophy type 2
    Valerio Pisani
    Department of Neurosciences, Universita di Roma Tor Vergata, and IRCCS Fondazione Santa Lucia, Via Montpellier 1, I 00133, Rome, Italy
    Muscle Nerve 38:1405-11. 2008
    ..Thus, morphometric and fiber type-based histological analysis of muscle biopsies may help differentiate between DM1 and DM2 and guide molecular analysis...
  7. ncbi Overexpression of ErbB2 and ErbB3 receptors in Schwann cells of patients with Charcot-Marie-tooth disease type 1A
    Roberto Massa
    Dipartimento di Neuroscienze, Universita di Roma Tor Vergata, Via Montpellier 1, I 00133 Roma, Italy
    Muscle Nerve 33:342-9. 2006
    ..The upregulation of these receptors may play a role in the inhibition of myelination or in the promotion of recurrent demyelination and axonal damage...
  8. ncbi Effect of the [CCTG]n repeat expansion on ZNF9 expression in myotonic dystrophy type II (DM2)
    Annalisa Botta
    Department of Biopathology, Tor Vergata University, Rome, Italy
    Biochim Biophys Acta 1762:329-34. 2006
    ..Our results indicate that the (CCTG)n expansion in the ZNF9 intron does not appear to have a direct consequence on the expression of the gene itself...
  9. ncbi Risk prediction for clinical phenotype in myotonic dystrophy type 1: data from 2,650 patients
    Leila Baghernajad Salehi
    Department of Biopathology and Diagnostic Imaging, Tor Vergata University, Rome, Italy
    Genet Test 11:84-90. 2007
    ..This study demonstrates that measurement of triplet expansions in patients' DNA can be considered as a useful tool for DM1 phenotype assessment and presymptomatic testing...
  10. ncbi Inverse correlation between VEGF and soluble VEGF receptor 2 in POEMS with AIDP responsive to intravenous immunoglobulin
    Chiara Terracciano
    Department of Neurosciences, Tor Vergata University of Rome and IRCCS Fondazione Santa Lucia, Rome, Italy
    Muscle Nerve 42:445-8. 2010
    ..sVEGFR2 reduction is a new finding in POEMS. IVIg treatment may benefit POEMS patients with acute neuropathy by downgrading VEGF release induced by inflammatory cytokines...
  11. ncbi Long-term outcome of thoracoscopic extended thymectomy for nonthymomatous myasthenia gravis
    Eugenio Pompeo
    Department of Thoracic Surgery, Myasthenia Gravis Unit, Policlinico Tor Vergata University, Rome, Italy
    Eur J Cardiothorac Surg 36:164-9. 2009
    ..The aim of this study was to analyze long-term (>5 years) results of thoracoscopic extended thymectomy in nonthymomatous MG...
  12. ncbi Nitrergic neurons make synapses on dual-input dendritic spines of neurons in the cerebral cortex and the striatum of the rat: implication for a postsynaptic action of nitric oxide
    G Sancesario
    Department of Neuroscience, The University of Rome Tor Vergata, Via di Tor Vergata 135, 00133, Rome, Italy
    Neuroscience 99:627-42. 2000
    ....
  13. ncbi Subacute demyelinating polyneuropathy in B-cell lymphoma with IgM antibodies against glycolipid GD1b
    G A Marfia
    Clinica Neurologica, Dipartimento di Neuroscienze, Universita di Roma Tor Vergata, Via Oxford 81, I 00133 Rome, Italy
    Neurol Sci 26:355-7. 2005
    ..The IgM type of these autoantibodies suggests that they represent all or part of the paraprotein produced by lymphoma cells...
  14. ncbi Peripheral nerve extracellular matrix remodeling in Charcot-Marie-Tooth type I disease
    Camilla Palumbo
    Dipartimento di Medicina Sperimentale e Scienze Biochimiche, , Via di Tor Vergata 135, 00133 Rome, Italy
    Acta Neuropathol (Berl) 104:287-96. 2002
    ..Thus, compared with our pathological controls CMT1 seemed to determine the most extensive remodeling of peripheral nerve ECM...
  15. ncbi Upper motor neuron involvement in X-linked recessive bulbospinal muscular atrophy
    C Pachatz
    Clinica Neurologica, Dipartimento di Neuroscienze, Universita di Roma Tor Vergata, Via Montpellier 1, 00133 Roma, Italy
    Clin Neurophysiol 118:262-8. 2007
    ..The aim of our study was to investigate the presence of subclinical upper motor neuron (UMN) dysfunction in this disease...
  16. ncbi Partial block of glycolysis in late-onset phosphofructokinase deficiency myopathy
    R Massa
    Clinica Neurologica, Universita di Roma Tor Vergata, Italy
    Acta Neuropathol 91:322-9. 1996
    ....